XML 49 R35.htm IDEA: XBRL DOCUMENT
v3.2.0.727

Investments in and Advances to Unconsolidated Joint Ventures (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2015
Investments in and Advances to Unconsolidated Joint Ventures |
Company owned interests in entities, accounted under equity method (dollars in thousands) |
Entity(1) |  | Segment |  | Carrying Amount |  | Ownership% |
CCRC JV(2) |  | senior housing |  | $ | 452,283 |  |  | 49 |  |
HCRMC |  | post-acute/skilled nursing |  |  | 50,958 |  |  | 9 |  |
MBK JV |  | senior housing |  |  | 27,139 |  |  | 50 |  |
HCP Ventures III, LLC |  | medical office |  |  | 6,408 |  |  | 30 |  |
HCP Ventures IV, LLC |  | medical office and hospital |  |  | 25,432 |  |  | 20 |  |
HCP Life Science(3) |  | life science |  |  | 69,293 |  | 50 | – | 63 |
Vintage Park |  | senior housing |  |  | 4,737 |  |  | 85 |  |
Suburban Properties, LLC |  | medical office |  |  | 5,112 |  |  | 67 |  |
Advances to unconsolidated joint ventures, net |  |  |  |  | 125 |  |  |  |  |
|  |  |  | $ | 641,487 |  |  |  |  |
| (1) |  | These entities are not consolidated because the Company does not control, through voting rights or other means, the joint ventures.
| (2) |  | Includes two unconsolidated joint ventures in a RIDEA structure: (i) “CCRC PropCo” and (ii) “CCRC OpCo”.
| (3) |  | Includes three unconsolidated joint ventures between the Company and an institutional capital partner. HCP Life Science includes the following partnerships (and the Company’s ownership percentage): (i) Torrey Pines Science Center, LP (50%); (ii) Britannia Biotech Gateway, LP (55%); and (iii) LASDK, LP (63%).
Summarized combined financial information for equity method investments (in thousands) |
|  | June 30, |  | December 31, |
|  | 2015 |  | 2014 |
Real estate, net |  | $ | 5,219,661 |  | $ | 5,134,587 |
Goodwill and other assets, net |  |  | 5,065,096 |  |  | 4,986,310 |
Total assets |  | $ | 10,284,757 |  | $ | 10,120,897 |
Capital lease obligations and debt |  | $ | 7,210,974 |  | $ | 7,197,940 |
Accounts payable |  |  | 1,127,561 |  |  | 1,015,912 |
Other partners’ capital |  |  | 1,299,578 |  |  | 1,281,413 |
HCP’s capital(1) |  |  | 646,644 |  |  | 625,632 |
Total liabilities and partners’ capital |  | $ | 10,284,757 |  | $ | 10,120,897 |
| (1) |  | The combined basis difference of the Company’s investments in these joint ventures of $5 million, as of June 30, 2015, is attributable to goodwill, real estate, capital lease obligations, deferred tax assets and lease-related net intangibles.
|  | Three Months Ended June 30, |  | Six Months Ended June 30, |
|  | 2015 |  | 2014 |  | 2015 |  | 2014 |
Total revenues |  | $ | 1,142,647 |  | $ | 1,059,455 |  | $ | 2,309,127 |  | $ | 2,126,943 |
Loss from discontinued operations |  |  | (7,100) |  |  | (6,200) |  |  | (6,000) |  |  | (8,800) |
Net loss |  |  | (21,528) |  |  | (11,834) |  |  | (11,730) |  |  | (3,973) |
HCP’s share of earnings(1) |  |  | 12,001 |  |  | 14,692 |  |  | 25,602 |  |  | 29,220 |
Fees earned by HCP |  |  | 458 |  |  | 444 |  |  | 918 |  |  | 893 |
Distributions received by HCP |  |  | 2,306 |  |  | 566 |  |  | 4,487 |  |  | 3,768 |
| (1) |  | The Company’s joint venture interest in HCRMC is accounted for using the equity method and results in an ongoing elimination of DFL income proportional to HCP’s ownership in HCRMC. The elimination of the respective proportional lease expense at the HCRMC level in substance results in $15 million and $16 million of DFL income that is recharacterized to the Company’s share of earnings from HCRMC (equity income from unconsolidated joint ventures) for the three months ended June 30, 2015 and 2014, respectively. For the six months ended June 30, 2015 and 2014, $30 million and $31 million, respectively, of DFL income was recharacterized to the Company’s share of earnings from HCR ManorCare.

X
- Definition Tabular disclosure of summarized financial information for the entity's unconsolidated joint ventures. + References No definition available. + Details
Name: | hcp_EquityMethodInvestmentsFinancialInformationTableTextBlock
Namespace Prefix: | hcp_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6382943&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration